Alveolus Bio

About:

Alveolus Bio is pursuing the development of novel FDA-approved therapeutics to address chronic respiratory illnesses.

Website: https://www.alveolusbio.com/

Top Investors: National Heart, Lung and Blood Institute, Innovate Alabama

Description:

Alveolus Bio: Alveolus Bio is a team of scientists, physicians, and innovators pioneering breakthrough FDA-approved therapeutics for lung diseases. Their clinical pipeline includes preclinical phase live biotherapeutics for Bronchopulmonary Dysplasia (BPD), Chronic Obstructive Pulmonary Disease (COPD), Idiopathic Pulmonary Fibrosis (IPF), and Pulmonary Arterial Hypertension (PAH).